Ridogrel

小分子

利多格雷

Ridogrel

R655122-1ml

1ml

10mM in DMSO

-80℃储存

超低温冰袋运输

Ridogrel (R 68070) is an orally active combined thromboxane A2 synthetase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor blocker. Ridogrel is potent antiplatelet agent. Anti-inflammatory activities . In Vitro In rats, R 68 070 (1.25 mg/kg orally, -2 h) singly prolongs tail bleeding times as much as a combination of TXA2 synthetase inhibition (dazoxiben 10 mg/kg) and TXA2/prostaglandin endoperoxide receptor blockade (BM 13177 40 mg/kg). In dogs, the compound reduces coronary thrombosis induced by electrical damage (1.25 mg/kg i.v.) and prevents the evolution of occlusion/reperfusion-induced arrhythmias into ventricular fibrillation (2.5 mg/kg i.v.) [2 . MCE has not independently confirmed the accuracy of these methods. They are for reference only.

利多格瑞（R 68070）是一种口服活性血栓素 A2 合成酶抑制剂和血栓素 A2/前列腺素内过氧化物受体阻断剂的复方制剂。利多格列是一种强效抗血小板药。抗炎活性。

110140-89-1(DMSO)

C18H17F3N2O3

366.33 g/mol

C1=CC(=CC(=C1)C(F)(F)F)C(=NOCCCCC(=O)O)C2=CN=CC=C2